As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
Platform II Explored: Revolutionising Construction with Head of Global Systems, Jaimie Johnston MBE
Built Environment Matters
5 minutes
2 years ago
Platform II Explored: Revolutionising Construction with Head of Global Systems, Jaimie Johnston MBE
Welcome to another episode of Bryden Wood's 'Built Environment Matters' podcast, where we delve into the transformative world of Platform II. In this episode, Jaimie Johnston MBE explores how Platform II is setting new benchmarks in the construction industry. Discover the innovative strategies behind the design and implementation of The Forge, the first building constructed using the P-DfMA approach. Uncover the benefits of sustainability, efficiency, and customisability that Platform II brin...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
